FLUOROURACILE TEVA 5000 mg/100 ml, concentrate for solution for infusion bottle, 100 ml
Active ingredients: FLUOROURACILE
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 100 mlintraartérielle;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FLUOROURACILE TEVA 5000 mg/100 mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraartérielle;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 100 ml
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61146475CIP75604346CIP133400956043460Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUOROURACILEsolution | 5000,00 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.